Page - 5 - in Advances in Neuroimmunology
Image of the Page - 5 -
Text of the Page - 5 -
BrainSci. 2016,6, 19
fromastrocyteculturespreparedfromCNSofnon-tgmice. Interestingly,ELISAanalysisof IL-6 levels
in the hippocampus have revealed low levels andnodifferences between the IL-6 tg andnon-tg
hippocampus,althoughhigher levelsandgenotypicdifferenceswerenoted in thecerebellum[52,56].
ThecerebellumistheCNSregionwiththehighestlevelofIL-6mRNAexpressioninthetransgenicmice,
particularly in theBergmanglial [49]. Theseresultsmayindicate that IL-6producedbyhippocampal
astrocytes invivo is rapidly releasedanddegraded.Othershavenoteddifficulty inmeasuring IL-6
levels inCNStissueusingcommercialELISAkits,whichmaymean that thereare technical issues
toberesolved[57]. Inspiteof the lackofdifferences inmeasureable levelsof IL-6protein, increase
expressionof IL-6 regulatedgenes (e.g., GFAP, eb22, Socs3) andelevated levels of STAT3and the
activatedformofSTAT3(phosphoSTAT3), thedownstreampartnerof IL-6signal transductionthrough
whichIL-6acts to increaseGFAP[58–60],wereobservedin theCNSof IL-6 tgmice. Theseresultsare
consistentwithactionsofelevated levelsof IL-6 in the IL-6 tgCNS.
Proteinmeasurements intheCNSofthetwoCCL2transgenic linesshowedthattheolderCCL2-tg
SJLmiceexpresshigher levelsofCCL2in thehippocampusthan in theCCL2-tgmice. CCL2levels
measuredbyELISAwere~1.3ng/mLat3–4monthsofageand~3.0ng/mLat7–9monthsofage in
hippocampalhomogenate fromtheCCL2-tgSJLmice[61]. In theCCL2-tgmice,CCL2levelsmeasured
byELISAwere~1.2 ng/mLat 3–5months of age and~1.5 ng/mLat 7–9 [58]. CCL2 levelswere
~0.2ng/mLinhippocampalhomogenates fromthenon-tgmice fromboththeCCL2-tgandCCL2-tg
SJL lines. Studiesof supernatants fromastrocyteculturesprepared fromCNSofCCL2-tgSJLmice
showedthatastrocytesconstitutivelysecrete largeamountsofCCL2(e.g.,~3.5ng/mL)[34].
ExpressionofCXCL-10 in theCNSofCXCL10-tgmicehasbeencharacterizedat themRNAlevel
by in situhybridization [29]. Thehighest levelsofCXCL10mRNAwereobserved in thehippocampus,
olfactorybulb,periventricularzone, corticalareas, cerebellum,andchoroidplexusof theCXCL10-tg
CNS (mice 5–6months of age). Western blot studies confirmedhigh levels ofCXCL10protein in
thehippocampus, and immunohistochemical stainingconfirmedexpressionofCXCL10protein in
astrocytes [29]. NoCXCL10mRNAorprotein expressionwasobserved innon-tgmice. Levels of
CXCL10protein in theCNSofCXCL10-tgmicehavenotbeenmeasuredbyELISA.
Elevated levelsofneuroimmune factors are typically associatedwithpathological conditions,
whereaslowlevelsappeartoexistunderphysiologicalconditions.However, therangeofproteinlevels
expressedduringphysiologicalandpathophysiological conditionshasyet tobefullyelucidatedfor
mostneuroimmunefactors.Althoughelevated levels IL-6,CCL2andCXCL-10mRNAand/orprotein
havebeendocumented in theCNSof therespective transgenicmice, it isunknownifprotein levels for
the three transgenic linesare functionallycomparable.However,mRNAorprotein levelswereshown
tobewithin therangeassociatedwithexperimentally inducedpathophysiologicalconditions in the
CNSof IL-6 tg [62],CXCL10-tg [29]andCCL2-tgSJLmice [34].
4.2.Neuropathology
Ingeneral,before3–6monthsofage, theheterozygousIL-6,CCL2,andCXCL10transgenicmice
showrelatively littleneuropathology. In the IL-6 tgmice, the cerebellumshows thehighest levels
of IL-6mRNAexpression in theCNSof the IL-6 tgmice andgreatest neuropathological changes,
themostprominentbeingneovascularization[49,63].Age-dependentneuropathological changes in
the cortex andhippocampusof the IL-6 tgmicewere evident in immunohistochemical studies of
synapticandcellularproteins. Theneuropathological changes includedreducedimmunostainingfor
thepresynapticproteinsynapsin I indicativeofsynapticdamage(cortex,12monthsofage), reduced
immunostainingformicrotubuleassociatedprotein-2 (MAP-2) indicativeofdendriticdamage(cortex
at 3 and12monthsof age), reduced immunostaining forparvalbumin, a calciumbindingprotein
expressedbyinhibitory interneurons (hippocampusat3and12monthsofage),andeventual lossof
the interneurons,andreducedimmunostainingforcalbindin,acalciumbindingproteinexpressedby
inhibitory interneurons (cortex,12monthsofage) [49,54].
5
back to the
book Advances in Neuroimmunology"
Advances in Neuroimmunology
- Title
- Advances in Neuroimmunology
- Author
- Donna Gruol
- Editor
- MDPI
- Location
- Basel
- Date
- 2017
- Language
- English
- License
- CC BY-NC-ND 4.0
- ISBN
- 978-3-03842-571-7
- Size
- 17.0 x 24.0 cm
- Pages
- 164
- Keywords
- neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
- Category
- Medizin